The global Bone Densitometers Market Growth Accelerated by Rising Osteoporosis Cases

 Bone densitometers are medical devices used to measure bone mineral density and diagnose osteoporosis. These devices help identify patients at risk of bone fractures. Osteoporosis, a condition characterized by low bone mass and structural deterioration of bone tissue, is a major public health issue that results in bone fractures. It is estimated that over 200 million people suffer from this condition worldwide. The rising cases of osteoporosis globally have fuelled the demand for bone densitometers for diagnosis and monitoring of the disease.

The global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The surging geriatric population prone to osteoporosis has been a key driver propelling the demand for bone densitometers. As per WHO, the number of people aged 65 years and above is projected to rise from 703 million in 2019 to 1.5 billion in 2050 globally. Age is a major risk factor for bone loss and osteoporosis. Moreover, improving accessibility of bone densitometers coupled with rising awareness about osteoporosis screening have boosted the uptake of these devices across healthcare settings over the past few years. However, high device costs remain a major challenge, especially in price-sensitive developing markets. Manufacturers are focusing on developing affordable bone densitometers to expand access in such regions.

Segment Analysis
The global bone densitometers market is segmented by type, technology, application, and end-user. Based on type, the market is classified into dual-energy X-ray, absorptiometry (DXA), peripheral, quantitative computed tomography (QCT), and others. DXA dominates the segment as they are widely considered the gold standard for measuring bone mineral density. Based on technology, the market is bifurcated into axial bone densitometry and peripheral bone densitometry. Axial bone densitometry holds major share due to its high accuracy and precise measurements of BMD at the hip and spine.

Key Takeaways
The global bone densitometers market is expected to witness high growth over the forecast period. The global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030.

Regional analysis:
The Asia Pacific region is expected to grow at the fastest rate during the forecast period owing to factors such as growing geriatric population and increasing prevalence of osteoporosis in countries such as India and China. Within Asia Pacific, China is expected to dominate the regional market owing to increasing healthcare expenditure and improved access to diagnosis and treatment of osteoporosis.

Key players:
Key players operating in the bone densitometers market are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare holds a major share of the market owing to its vast product portfolio and global presence. Hologic, Inc. also has a significant share due to its innovative product offerings and robust distribution networks across major markets.